Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Budach

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Biology|August 27, 2002
Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biologyC Belka, W Budach
Der Radiologe|December 1, 1992
[Radiotherapeutic strategies for soft tissue sarcomas in adults]V Budach, S Dinges, W Budach
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Radiosensitivity and local tumor control--experimental studiesV Budach, M Stuschke, W Budach
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Local recurrences of soft tissue sarcomas--a therapeutic challengeV Budach, M Stuschke, W Budach
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 27, 1998
Individual skin care during radiation therapyJ S Zimmermann, W Budach, W Dörr
Cell Death and Differentiation|April 9, 2011
Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1)D Sohn, W Budach, R U Jänicke
Radiation Research|May 1, 1990
Methods for analysis of censored tumor growth delay dataM Stuschke, V Budach, M Bamberg, et al.
Radiation Research|April 1, 1993
In vitro split-dose recovery of glioblastoma multiformeA Taghian, D Gioioso, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 1, 1989
Primary chemosensitivity and secondary drug resistance of xenografted soft part sarcomasV Budach, W Budach, M Scheulen, et al.
Laryngo- Rhino- Otologie|September 11, 2023
[Therapy of tumor recurrences or secondary carcinomas in pretreated area is not compatible with the primary therapy in non-previously treated tissue - an overview]Andreas Dietz, S Wiegand, H Bläker, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Biology|August 27, 2002
Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biologyC Belka, W Budach
Der Radiologe|December 1, 1992
[Radiotherapeutic strategies for soft tissue sarcomas in adults]V Budach, S Dinges, W Budach
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Radiosensitivity and local tumor control--experimental studiesV Budach, M Stuschke, W Budach
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Local recurrences of soft tissue sarcomas--a therapeutic challengeV Budach, M Stuschke, W Budach
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 27, 1998
Individual skin care during radiation therapyJ S Zimmermann, W Budach, W Dörr
Cell Death and Differentiation|April 9, 2011
Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1)D Sohn, W Budach, R U Jänicke
Radiation Research|May 1, 1990
Methods for analysis of censored tumor growth delay dataM Stuschke, V Budach, M Bamberg, et al.
Radiation Research|April 1, 1993
In vitro split-dose recovery of glioblastoma multiformeA Taghian, D Gioioso, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 1, 1989
Primary chemosensitivity and secondary drug resistance of xenografted soft part sarcomasV Budach, W Budach, M Scheulen, et al.
Laryngo- Rhino- Otologie|September 11, 2023
[Therapy of tumor recurrences or secondary carcinomas in pretreated area is not compatible with the primary therapy in non-previously treated tissue - an overview]Andreas Dietz, S Wiegand, H Bläker, et al.
Pageof 14